Veeva Systems (NYSE:VEEV – Get Free Report) is one of 93 public companies in the “Healthcare Technology” industry, but how does it contrast to its rivals? We will compare Veeva Systems to related businesses based on the strength of its valuation, risk, analyst recommendations, profitability, dividends, earnings and institutional ownership.
Risk and Volatility
Veeva Systems has a beta of 0.89, suggesting that its stock price is 11% less volatile than the S&P 500. Comparatively, Veeva Systems’ rivals have a beta of 1.11, suggesting that their average stock price is 11% more volatile than the S&P 500.
Valuation & Earnings
This table compares Veeva Systems and its rivals top-line revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Veeva Systems | $3.46 billion | $908.91 million | 49.65 |
| Veeva Systems Competitors | $350.65 million | -$24.15 million | 12.26 |
Veeva Systems has higher revenue and earnings than its rivals. Veeva Systems is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.
Profitability
This table compares Veeva Systems and its rivals’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Veeva Systems | 29.34% | 14.25% | 11.71% |
| Veeva Systems Competitors | -749.77% | -28.38% | -15.05% |
Institutional & Insider Ownership
88.2% of Veeva Systems shares are held by institutional investors. Comparatively, 42.4% of shares of all “Healthcare Technology” companies are held by institutional investors. 10.6% of Veeva Systems shares are held by insiders. Comparatively, 16.2% of shares of all “Healthcare Technology” companies are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Analyst Ratings
This is a breakdown of current ratings and price targets for Veeva Systems and its rivals, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Veeva Systems | 1 | 8 | 19 | 0 | 2.64 |
| Veeva Systems Competitors | 455 | 1537 | 2754 | 89 | 2.51 |
Veeva Systems currently has a consensus target price of $317.42, suggesting a potential upside of 5.15%. As a group, “Healthcare Technology” companies have a potential upside of 52.07%. Given Veeva Systems’ rivals higher probable upside, analysts plainly believe Veeva Systems has less favorable growth aspects than its rivals.
Summary
Veeva Systems beats its rivals on 9 of the 13 factors compared.
Veeva Systems Company Profile
Veeva Systems Inc. develops cloud-based software, data and consulting services for the life sciences industry. Its customers include pharmaceutical and biotechnology companies, medical device makers and contract research organizations. The company’s products support commercial operations as well as clinical, regulatory, quality and safety activities. Its offerings include Veeva Vault applications for managing documents and business processes, customer relationship management software, and data and analytics services.
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
